Skip to main content

Publisher: Wiley-Blackwell

Volume 29, Number 5, 1 May 2012

Statins and glycaemic control—a cause for concern?
pp. 557-557(1)
Author: Hitman, G. A.

Favourites:
ADD

Hypoglycaemia during pregnancy in women with Type 1 diabetes
pp. 558-566(9)
Authors: Ringholm, L.; Pedersen‐Bjergaard, U.; Thorsteinsson, B.; Damm, P.; Mathiesen, E. R.

Favourites:
ADD

Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review
pp. 567-577(11)
Authors: Hellemons, M. E.; Kerschbaum, J.; Bakker, S. J. L.; Neuwirt, H.; Mayer, B.; Mayer, G.; de Zeeuw, D.; Lambers Heerspink, H. J.; Rudnicki, M.

Favourites:
ADD

Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy
pp. 578-585(8)
Authors: Spallone, V.; Morganti, R.; D’Amato, C.; Greco, C.; Cacciotti, L.; Marfia, G. A.

Favourites:
ADD

Types of smokers in a community sample of individuals with Type 2 diabetes: a latent class analysis
pp. 586-592(7)
Authors: Gariepy, G.; Malla, A.; Wang, J.; Messier, L.; Strychar, I.; Lesage, A.; Schmitz, N.

Favourites:
ADD

Physical activity, family history of diabetes and risk of developing hyperglycaemia and diabetes among adults in Mainland China
pp. 593-599(7)
Authors: Xu, F.; Wang, Y.; Ware, R. S.; Tse, L. Ah; Dunstan, D. W.; Liang, Y.; Wang, Z.; Hong, X.; Owen, N.

Favourites:
ADD

Effects of variations in duodenal glucose load on glycaemic, insulin, and incretin responses in type 2 diabetes
pp. 604-608(5)
Authors: Ma, J.; Pilichiewicz, A. N.; Feinle‐Bisset, C.; Wishart, J. M.; Jones, K. L.; Horowitz, M.; Rayner, C. K.

Favourites:
ADD

Dynamic cerebral autoregulation assessed by respiratory manoeuvres in non‐insulin‐treated Type 2 diabetes mellitus
pp. 609-613(5)
Authors: Huq, R.; Philbey, C. E.; Mistri, A. K.; Panerai, R. B.; Robinson, T. G.

Favourites:
ADD

Risk of acute renal failure in patients with Type 2 diabetes mellitus
pp. 614-621(8)
Authors: Girman, C. J.; Kou, T. D.; Brodovicz, K.; Alexander, C. M.; O’Neill, E. A.; Engel, S.; Williams‐Herman, D. E.; Katz, L.

Favourites:
ADD

Impact of increased visceral and cardiac fat on cardiometabolic risk and disease
pp. 622-627(6)
Authors: Sironi, A. M.; Petz, R.; De Marchi, D.; Buzzigoli, E.; Ciociaro, D.; Positano, V.; Lombardi, M.; Ferrannini, E.; Gastaldelli, A.

Favourites:
ADD

Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes—the CORALL study
pp. 628-631(4)
Authors: Simsek, S.; Schalkwijk, C. G.; Wolffenbuttel, B. H. R.

Favourites:
ADD

Differences in the quality of diabetes care caused by social inequalities disappear after treatment and education in a tertiary care centre
pp. 640-645(6)
Authors: Bäz, L.; Müller, N.; Beluchin, E.; Kloos, C.; Lehmann, T.; Wolf, G.; Müller, U. A.

Favourites:
ADD

Health‐related quality of life in subjects with and without Type 2 diabetes: pooled analysis of five population‐based surveys in Germany
pp. 646-653(8)
Authors: Schunk, M.; Reitmeir, P.; Schipf, S.; Völzke, H.; Meisinger, C.; Thorand, B.; Kluttig, A.; Greiser, K.‐H.; Berger, K.; Müller, G.; Ellert, U.; Neuhauser, H.; Tamayo, T.; Rathmann, W.; Holle, R.

Favourites:
ADD

Social support and self‐management behaviour among patients with Type 2 diabetes
pp. 654-661(8)
Authors: Schiøtz, M. L.; Bøgelund, M.; Almdal, T.; Jensen, B. B.; Willaing, I.

Favourites:
ADD

Poor numeracy skills are associated with glycaemic control in Type 1 diabetes
pp. 662-669(8)
Authors: Marden, S.; Thomas, P. W.; Sheppard, Z. A.; Knott, J.; Lueddeke, J.; Kerr, D.

Favourites:
ADD

Dose Adjustment for Normal Eating (DAFNE) in routine clinical practice: who benefits?
pp. 670-676(7)
Authors: Keen, A. J. A.; Duncan, E.; McKillop‐Smith, A.; Evans, N. D.; Gold, A. E.

Favourites:
ADD

Working with young adults with Type 1 diabetes: Views of a multidisciplinary care team and implications for service delivery
pp. 677-681(5)
Authors: Brierley, S.; Eiser, C.; Johnson, B.; Young, V.; Heller, S.

Favourites:
ADD

Insulin adherence behaviours and barriers in the multinational Global Attitudes of Patients and Physicians in Insulin Therapy study
pp. 682-689(8)
Authors: Peyrot, M.; Barnett, A. H.; Meneghini, L. F.; Schumm‐Draeger, P.‐M.

Favourites:
ADD

Insulin avoidance and treatment outcomes among patients with a professional driving licence starting glucagon‐like peptide 1 (GLP‐1) agonists in the Association of British Clinical Diabetologists (ABCD) nationwide exenatide and liraglutide audits
pp. 690-692(3)
Authors: Thong, K. Y.; Ryder, R. E. J.; Cull, M. L.; Walton, C.; on behalf of the ABCD nationwide exenatide and liraglutide audit contributors (for list of contributors, see Supporting Information, Appendix S2)cr5

Favourites:
ADD

Effective treatment of diabetes caused by activating ABCC8/SUR1 mutation with glimepiride
pp. 692-693(2)
Authors: Karges, B.; Schnur, D.; Ellard, S.; Kentrup, H.; Karges, W.

Favourites:
ADD
Favourites:
ADD

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
X
Cookie Policy
ingentaconnect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more